Qube Research & Technologies (QRT)’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,240
| Closed | -$13.7K | – | 3200 |
|
|
2024
Q3 | $13.7K | Sell |
1,240
-610
| -33% | -$6.76K | ﹤0.01% | 2485 |
|
|
2024
Q2 | $17.2K | Buy |
+1,850
| New | +$17.2K | ﹤0.01% | 2514 |
|
|
2023
Q4 | – | Sell |
-92
| Closed | -$5.55K | – | 4266 |
|
|
2023
Q3 | $5.55K | Sell |
92
-2,318
| -96% | -$140K | ﹤0.01% | 2995 |
|
|
2023
Q2 | $246K | Buy |
2,410
+1,989
| +472% | +$203K | ﹤0.01% | 1648 |
|
|
2023
Q1 | $74.4K | Buy |
+421
| New | +$74.4K | ﹤0.01% | 2115 |
|
|
2022
Q4 | – | Sell |
-874
| Closed | -$295K | – | 3021 |
|
|
2022
Q3 | $295K | Sell |
874
-1,226
| -58% | -$414K | ﹤0.01% | 1583 |
|
|
2022
Q2 | $690K | Buy |
2,100
+1,627
| +344% | +$535K | 0.01% | 1270 |
|
|
2022
Q1 | $207K | Buy |
+473
| New | +$207K | ﹤0.01% | 1916 |
|